Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy

Jingjing Ren(Yale University), Michael Girardi(Yale University)
Nature Communications
January 15, 2024
Cited by 20


Related Papers